Nektar Therapeutics
NKTR
#4574
Rank
โ‚ฌ1.87 B
Marketcap
65,26ย โ‚ฌ
Share price
2.03%
Change (1 day)
874.97%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚ฌ0.16 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ0.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ0.16 B-30.56%
2024-12-31โ‚ฌ0.23 B-3.29%
2023-12-31โ‚ฌ0.24 B-24.66%
2022-12-31โ‚ฌ0.32 B-17.03%
2021-12-31โ‚ฌ0.38 B3.01%
2020-12-31โ‚ฌ0.37 B-26.52%
2019-12-31โ‚ฌ0.51 B35.02%
2018-12-31โ‚ฌ0.37 B7.76%
2017-12-31โ‚ฌ0.35 B-23.22%
2016-12-31โ‚ฌ0.45 B1.53%
2015-12-31โ‚ฌ0.45 B35.09%
2014-12-31โ‚ฌ0.33 B-12.25%
2013-12-31โ‚ฌ0.37 B11.43%
2012-12-31โ‚ฌ0.34 B8.27%
2011-12-31โ‚ฌ0.31 B-2.77%
2010-12-31โ‚ฌ0.32 B-1.98%
2009-12-31โ‚ฌ0.33 B24.65%
2008-12-31โ‚ฌ0.26 B-24.25%
2007-12-31โ‚ฌ0.34 B-14.72%
2006-12-31โ‚ฌ0.41 B-8.64%
2005-12-31โ‚ฌ0.44 B119.36%
2004-12-31โ‚ฌ0.20 B-43.08%
2003-12-31โ‚ฌ0.35 B-6.02%
2002-12-31โ‚ฌ0.38 B-14.89%
2001-12-31โ‚ฌ0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ100.72 B 61,642.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ103.90 B 63,594.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ70.13 B 42,890.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ11.94 B 7,221.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ72.07 B 44,084.41%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ55.94 B 34,193.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚ฌ37.05 M-77.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.57 B 250.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland